Observational study of patients with systemic amyloidosis
Observational Epidemiological Study of Patients Suffering From Systemic Amyloidosis
IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06866912
This study looks at patients with systemic amyloidosis, especially those with heart issues, to learn more about their experiences and outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 750 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna (other) |
| Locations | 1 site (Bologna) |
| Trial ID | NCT06866912 on ClinicalTrials.gov |
What this trial studies
This observational epidemiological study focuses on patients diagnosed with systemic amyloidosis, particularly those with cardiac involvement. It aims to gather data on the characteristics and outcomes of these patients to better understand the disease's impact. The study will include both symptomatic patients and asymptomatic carriers of mutations in the transthyretin gene, allowing for a comprehensive analysis of the condition. Participants will be recruited from a single institution in Bologna, Italy.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older diagnosed with amyloidosis or asymptomatic carriers of transthyretin gene mutations.
Not a fit: Patients who do not have amyloidosis or are under 18 years old may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of systemic amyloidosis and improve patient management strategies.
How similar studies have performed: While observational studies on amyloidosis exist, this specific approach focusing on systemic amyloidosis and its cardiac implications may provide novel insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients diagnosed with amyloidosis or asymptomatic carriers of mutations in the transthyretin gene * minimum age of 18 years at the time of diagnosis * obtaining informed consent Exclusion Criteria: * nothing
Where this trial is running
Bologna
- IRCCS Azienda Ospedaliero-Universitaria di Bologna — Bologna, Italy (RECRUITING)
Study contacts
- Principal investigator: Simone Longhi, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Study coordinator: simone longhi, MD
- Email: simone.longhi@aosp.bo.it
- Phone: 00390512149039
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cardiomyopathy, Cardiac amyloidosis